TCL Archive SPOREs hammer out research agenda, seek $50,000 from NCI for further tissue analysis. April 30, 2004
TCL Archive Phase III Custirsen/Docetaxel/Prednisone Trial Fails Primary Endpoint of Overall Survival April 25, 2014